Intrexon Corporation (NYSE:XON) operates in the synthetic biology field.
Insider buying during the last 30 days
Here is a table of Intrexon's insider activity during the last 30 days.
|Name||Title||Trade Date||Shares Purchased||Current Ownership||Increase In Shares|
|Thomas Reed||CSO||May 13||640||334,785 shares||+0.2%|
|Donald Lehr||CLO||May 13||1,850||15,326 shares||+13.7%|
|Suma Krishnan||SVP||May 9||20,900||20,900 shares||from 0 to 20,900|
|Krish Krishnan||COO||May 9||20,900||20,900 shares||from 0 to 20,900|
|Thomas Kasser||SVP||May 9||10,000||15,000 shares||+200%|
|Kelly Huang||SVP||May 9||3,200||3,200 shares||from 0 to 3,200|
|Randal Kirk||CEO||May 9||65,173||62,632,080 shares||+0.1%|
There have been 122,663 shares purchased by insiders during the last 30 days.
Insider buying by calendar month
Here is a table of Intrexon's insider activity by calendar month.
|Month||Insider buying / shares||Insider selling / shares|
There have been 2,422,964 shares purchased and there have been zero shares sold by insiders since August 2013. Intrexon had its IPO in August 2013.
Intrexon reported the first-quarter financial results on May 1 with the following highlights:
|Net income||$4.1 million|
The seven insiders purchased their shares after these results.
|Qtrly Rev Growth (yoy):||0.98||0.67||0.02|
|PEG (5 yr expected):||N/A||1.05||2.82|
Intrexon has the fastest revenue growth among these three companies.
Here is a table of these competitors' insider activities this year.
|Company||Insider buying / shares||Insider selling / shares|
Only Intrexon has seen intensive insider buying during the last 30 days.
There have been seven different insiders buying Intrexon, and there have not been any insiders selling Intrexon during the last 30 days. Five of these seven insiders increased their holdings by more than 10%.
The seven insiders purchased their shares at prices ranging from $13.39 to $15.99. I believe Intrexon could be a good pick below $16, based on the intensive insider buying.
Disclosure: I have no positions in any stocks mentioned, but may initiate a long position in XON over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.